Figure 2

Kaplan-Meier survival analysis of PinX1 expression in patients with UCB (log-rank test). (A) Total, probability of overall survival of all patients with UCB: negative expression (dashed line), n = 83; positive expression (solid line), n = 104. (B) Adjuvant chemotherapy, probability of recurrence-free survival of patients underwent adjuvant chemotherapy with UCB: negative expression (dashed line), n = 27; positive expression (solid line), n = 20. (C) G1, probability of overall survival of G1 patients with UCB: negative expression (dashed line), n = 19; positive expression (solid line), n = 27. (D) G2, probability of overall survival of G2 patients with UCB: negative expression (dashed line), n = 29; positive expression (solid line), n = 37. (E) G3, probability of overall survival of G3 patients with UCB: negative expression (dashed line), n = 35; positive expression (solid line), n = 40. (F) pT1, probability of overall survival of pT1 patients with UCB: negative expression (dashed line), n = 13; positive expression (solid line), n = 22. (G) pT2, probability of overall survival of pT2 patients with UCB: negative expression (dashed line), n = 38; positive expression (solid line), n = 57. (H) pT3, probability of overall survival of pT3 patients with UCB: negative expression (dashed line), n = 20; positive expression (solid line), n = 17. (I) pT4-, probability of overall survival of pT4 patients with UCB: negative expression (dashed line), n = 12; positive expression (solid line), n = 8. (J) pN-, probability of overall survival of pN- patients with UCB: negative expression (dashed line), n = 64; positive expression (solid line), n = 93. (K) pN+, probability of overall survival of pN+ patients with UCB: negative expression (dashed line), n = 19; positive expression (solid line), n = 11.